Rare tumors pose special challenges in oncology because of their low frequency, heterogeneous biology, and sparse clinical data. The session "Rare Tumor Therapy" deals with strategies, innovations, and individualized approaches for the effective treatment of these rare malignancies.".
Rare tumor treatment may involve a multidisciplinary strategy, incorporating surgery, radiation, systemic therapy, and targeted or immunotherapies. Precision medicine, including molecular profiling, is important for defining actionable mutations and informing therapy choice, particularly where standard protocols don't exist. Case series, clinical trials, and registries assist in the generation of evidence supporting best practices for such rare cancers.
The session also discusses the emerging therapies, such as targeted therapies, cell-based immunotherapies, and new drug combinations specific to tumor-type molecular features. In order to develop knowledge and enhance outcomes for rare tumor patients, collaboration between institutions, patient advocacy groups, and research networks is critical.
Participants will be informed about clinical management, research, and new developments in novel treatment for rare tumors. The session underscores the value of personalized, evidence-based strategies in tackling the hurdles of rare cancers, holding out hope for enhanced survival, quality of life, and access to innovative treatments.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
